undamentalytics Newsletter

Cerenome vs Charming Medical

Cerenome and Charming Medical are similar in size: $5.2m and $4.8m of revenue in their latest fiscal years. Cerenome grew faster (-10.5% against -22.7%). Charming Medical kept more of each dollar of sales as profit: a net margin of -0.5% against -429.4%. Charming Medical carries less debt relative to equity (7.2% against 18.8%).

Latest fiscal yearCerenomeCNSY, 2025Charming MedicalMCTA, 2026
Revenue $5.2m $4.8m
Revenue growth -10.5% -22.7%
Net income −$22.4m −$22,648
Operating margin -293.5% -0.6%
Net margin -429.4% -0.5%
Return on equity — -0.9%
Free cash flow −$20.8m −$1.6m
Cash $4.3m $4.7m
Total debt $750,000 $371,598
Debt to equity 18.8% 7.2%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees 28 —
Market value $9.6m $474m
Price vs our value range — —
Moat score 18 (Weak) —
Insider trades, 12 months 1 buys, 0 sales 0 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.